US.BDX · Becton Dickinson

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.6353252374654326,
        "turnoverUsdM": 322.13554106,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.BDX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 157.5728,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 5.3,
      "take_profit_price": 176.6122,
      "target_multiplier": 1.9,
      "technical_strength": 1.85,
      "take_profit_percent": 6.2
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.270650474930865,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 91.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 59.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 32
  },
  "market": {
    "ma20": 155.0515,
    "ma50": 150.3162,
    "close": 166.34,
    "prevClose": 158.92,
    "avgVolume20": 1698620,
    "volumeRatio": 1.14,
    "changePercent": 4.67
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 32,
    "details": {
      "ret_5d": 0.08125325013000517,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 32,
      "vcp_bonus": 0,
      "vol_ratio": 1.124875988894181,
      "ret_points": 12,
      "vol_points": 2,
      "range_ratio": 1.6266974254051303,
      "volat_points": 4,
      "day_range_pct": 0.039647709510640845,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 1
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 91.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 6.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 42.67,
        "contribution": 6.4
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 22.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 74.33,
        "contribution": 22.3
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 59.2,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 6.4/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 22.3/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 2.9,
      "資金流": 10.8,
      "市場環境": 6.4,
      "情緒分析": 4,
      "技術信號": 22.3,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 322.13554106,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.4,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 1.6,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.BDX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.67
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 708.0634979000001,
                "ma50": 716.7494019999999,
                "name": "QQQ",
                "close": 675.48999,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.6510067000002,
                "ma50": 744.8574021799999,
                "name": "SPY",
                "close": 740.85999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6353252374654326,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140848822,
                "url": "https://finnhub.io/api/news?id=ea8b22bb235183cb7d1199e5a5818df545df38fb374baf1d8ade22c220e7ff04",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson stock has fallen 22.8% year to date, yet the valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both suggest the shares may now be trading at a discount to what the underlying cash flows imply. The share price is down 22.8% so far this year, which has opened up a gap between recent performance and what current valuation metrics indicate. The recent Vizient Innovative Technology contract for the CentroVena One Insertion System can...",
                "category": "company",
                "datetime": 1783581124,
                "headline": "Becton Dickinson (BDX) Stock Trades At A Discount On Cash Flow And Earnings"
              },
              {
                "id": 140848823,
                "url": "https://finnhub.io/api/news?id=563934d32aacb1eebb727bc7ace7ca2a2422de9287d411425732502c591be3ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (BDX) is back on investors’ radar after a reshuffle in Russell indices, with the stock added to the Russell Midcap Index and Russell Midcap Value Benchmark and removed from two Russell Top 200 indices. See our latest analysis for Becton Dickinson. At a share price of $150.56, Becton Dickinson has seen its 1 day share price return decline 3.67%, while the year to date share price return is down 22.77%. However, the 1 year total shareholder return of 11.85% suggests longer term...",
                "category": "company",
                "datetime": 1783577593,
                "headline": "Becton Dickinson (BDX) Joins New Russell Indexes, Is The Stock Below Fair Value?"
              },
              {
                "id": 140843573,
                "url": "https://finnhub.io/api/news?id=15a4f8be5033f5cfdfd578b4d8264b3be84898aa8b595bacefff543a37eb851f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1783527004,
                "headline": "Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 140778426,
                "url": "https://finnhub.io/api/news?id=67539a3ffd65f04ec9465c4dcd6ed59833c967b2e4269a76cae2a090d82941f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton, Dickinson & Company (NYSE:BDX) is one of the best value stocks to buy right now. On June 23, BD (Becton, Dickinson & Company) announced that its CentroVena One Insertion System was awarded an Innovative Technology contract by Vizient, the nation’s largest provider-driven healthcare performance improvement company. This contract recognizes the system as a breakthrough […]",
                "category": "company",
                "datetime": 1782893774,
                "headline": "BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System"
              }
            ],
            "raw_source": [
              {
                "id": 141047524,
                "url": "https://finnhub.io/api/news?id=8743b0e1b5291797757814be51579d2b5c647a6d45873d66f87d9ccbd6dbb01a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common share, payable on September 30, 2026, to holders of record on September 9, 2026. The indicated annual dividend rate is $4.20 per share.",
                "category": "company",
                "datetime": 1785269700,
                "headline": "BD Board Declares Dividend"
              },
              {
                "id": 141046965,
                "url": "https://finnhub.io/api/news?id=77fc9dcc4ad086b332ad2c6530a320aaa850f6ba8254cc07e7894950b7f57eed",
                "image": "",
                "source": "Benzinga",
                "related": "BDX",
                "summary": "UBS  analyst Patrick Wood   initiates coverage on Becton Dickinson (NYSE:BDX) with a Buy rating and announces Price Target of $190.",
                "category": "company",
                "datetime": 1785248618,
                "headline": "UBS Initiates Coverage On Becton Dickinson with Buy Rating, Announces Price Target of $190"
              },
              {
                "id": 141042644,
                "url": "https://finnhub.io/api/news?id=7507ca35b1cbe8e76ab6c5b9c089fdd29418dcb58a04e57f6822f7749625c588",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1785245664,
                "headline": "Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141041716,
                "url": "https://finnhub.io/api/news?id=2a86e4b8fd92ac62a83ec851d35f1e19f535387b356654c5c93fd6c2bfdd1cb0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made the biggest moves today.",
                "category": "company",
                "datetime": 1785238969,
                "headline": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More"
              },
              {
                "id": 141035101,
                "url": "https://finnhub.io/api/news?id=1030c034e8cbe3e61dd6ad76c34fbb29b759a77e80edf8b047749530be1c2491",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The chief investment strategist at Concurrent Asset Management shares her top investment picks right now.",
                "category": "company",
                "datetime": 1785167040,
                "headline": "Leah Bennett: Where to Invest After the AI-Chip Stock Surge"
              },
              {
                "id": 141033957,
                "url": "https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.",
                "category": "company",
                "datetime": 1785160469,
                "headline": "The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"
              },
              {
                "id": 141028474,
                "url": "https://finnhub.io/api/news?id=9a2687b22714d8cedc636831b2bc62592056cb84c4baeb1b206ee7ea9c167dc4",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2209914068/image_2209914068.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Dividend Kings beat SPY in June–July, reclaiming a YTD lead.",
                "category": "company",
                "datetime": 1785093714,
                "headline": "Best Dividend Kings: July 2026"
              },
              {
                "id": 141005352,
                "url": "https://finnhub.io/api/news?id=4d73431f2c3617f58fa67a24b0853a1ef831c63ec81636bc814893cef053e08a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Danaher's latest earnings call saw analysts repeatedly test one sore spot in an otherwise solid quarter, and management's answers reveal the key risk for investors now.",
                "category": "company",
                "datetime": 1784895812,
                "headline": "Reading Between The Lines Of DHR's Latest Call"
              },
              {
                "id": 140981118,
                "url": "https://finnhub.io/api/news?id=fa57a97243b0c83679edaf224c28781bce441132ed4de14c0178eea085657842",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BOSTON, July 22, 2026--AcuityMD, the AI platform for MedTech, today announced it is now trusted by more than 500 medical device (MedTech) companies, including 16 of the top 20, such as Becton Dickinson, Olympus, and Teleflex. The milestone reflects a growing shift across the medical device industry, as commercial teams adopt AI to better understand where care is happening and to uncover new opportunities. Across its customer base, AcuityMD has helped commercial teams generate billions in pipelin",
                "category": "company",
                "datetime": 1784718300,
                "headline": "AcuityMD Now Trusted By More Than 500 Medical Device Companies, Including 16 of Top 20"
              },
              {
                "id": 140981119,
                "url": "https://finnhub.io/api/news?id=f3b901d693739a1bf1e005232f579d704e735f6df658ab70d97906c9207655f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison has informed the company of his intent to retire after more than 20 years with BD, effective Oct. 2.",
                "category": "company",
                "datetime": 1784717700,
                "headline": "Mike Garrison to Retire from BD"
              },
              {
                "id": 140974912,
                "url": "https://finnhub.io/api/news?id=bbdead80568b813174817288369cedcdbc1558cbe69a3fa5d808987e69a9b82d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The market is offering a steep discount on this medical device maker, but the price tag comes with a story about slowing growth. Here’s how to read it.",
                "category": "company",
                "datetime": 1784660157,
                "headline": "Why BSX Stock Hands You So Much Cash Right Now"
              },
              {
                "id": 140975059,
                "url": "https://finnhub.io/api/news?id=91a4096b30adaf23aee0d3fe9fcd6a67cdcb516a9750543dc4b551d9db761ad0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton, Dickinson and Company will release its third-quarter earnings next month, and analysts anticipate a double-digit profit dip.",
                "category": "company",
                "datetime": 1784638704,
                "headline": "Becton, Dickinson and Company Earnings Preview: What to Expect"
              },
              {
                "id": 140914355,
                "url": "https://finnhub.io/api/news?id=246ba7e46eb7644e032fdd9b5f2abf1f0f0d9f113a64d3a29c958698fcf15496",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The S&P 500 index posted a total return of 9.9% from Jan. 2 through June 30. Here’s how our panelists’ picks did in that period.",
                "category": "company",
                "datetime": 1784143920,
                "headline": "How Barron’s Roundtable Panelists’ 2026 Picks Have Performed So Far"
              },
              {
                "id": 140855894,
                "url": "https://finnhub.io/api/news?id=1d26365581c0ba1b73153348aa6d63c1e790f4a69e3c47e3378b248a63ad2843",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, August 6, 2026 to discuss the Company's financial results for its third quarter of fiscal year 2026, which ended on June 30, 2026, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made available s",
                "category": "company",
                "datetime": 1783628100,
                "headline": "BD to Announce Financial Results for its Third Quarter of Fiscal 2026"
              },
              {
                "id": 140852127,
                "url": "https://finnhub.io/api/news?id=3dc0ae22f59ecc076a1a15b91bdc68fa65b5f68b674058d014aa38fddece5920",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "If you hold shares in this medical device maker, you are already carrying the full weight of a sizable potential swing that the market is pricing for the year ahead.",
                "category": "company",
                "datetime": 1783604422,
                "headline": "The Wide Chasm Priced Into Boston Scientific Stock"
              },
              {
                "id": 140848822,
                "url": "https://finnhub.io/api/news?id=ea8b22bb235183cb7d1199e5a5818df545df38fb374baf1d8ade22c220e7ff04",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson stock has fallen 22.8% year to date, yet the valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both suggest the shares may now be trading at a discount to what the underlying cash flows imply. The share price is down 22.8% so far this year, which has opened up a gap between recent performance and what current valuation metrics indicate. The recent Vizient Innovative Technology contract for the CentroVena One Insertion System can...",
                "category": "company",
                "datetime": 1783581124,
                "headline": "Becton Dickinson (BDX) Stock Trades At A Discount On Cash Flow And Earnings"
              },
              {
                "id": 140848823,
                "url": "https://finnhub.io/api/news?id=563934d32aacb1eebb727bc7ace7ca2a2422de9287d411425732502c591be3ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (BDX) is back on investors’ radar after a reshuffle in Russell indices, with the stock added to the Russell Midcap Index and Russell Midcap Value Benchmark and removed from two Russell Top 200 indices. See our latest analysis for Becton Dickinson. At a share price of $150.56, Becton Dickinson has seen its 1 day share price return decline 3.67%, while the year to date share price return is down 22.77%. However, the 1 year total shareholder return of 11.85% suggests longer term...",
                "category": "company",
                "datetime": 1783577593,
                "headline": "Becton Dickinson (BDX) Joins New Russell Indexes, Is The Stock Below Fair Value?"
              },
              {
                "id": 140843573,
                "url": "https://finnhub.io/api/news?id=15a4f8be5033f5cfdfd578b4d8264b3be84898aa8b595bacefff543a37eb851f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1783527004,
                "headline": "Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 140835347,
                "url": "https://finnhub.io/api/news?id=7c2ba7baa099679035fad5170d750e7121c1446d52ed53d54af19195f6b4a2f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Don't sleep on these medical device leaders.",
                "category": "company",
                "datetime": 1783461000,
                "headline": "Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom"
              },
              {
                "id": 140830065,
                "url": "https://finnhub.io/api/news?id=3c61c162eeb4a4ff55bbbf7eb416d76bd56a1411992abae065eed559761e61eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.",
                "category": "company",
                "datetime": 1783430548,
                "headline": "How To Target A 10% Yield While Catching The BSX Stock Knife?"
              },
              {
                "id": 140821788,
                "url": "https://finnhub.io/api/news?id=25b3a93687b8f773f29a1dcc1c467908902bb091355627cbd6112d9aabd028a3",
                "image": "",
                "source": "Benzinga",
                "related": "BDX",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Becton Dickinson (NYSE:BDX) with a Outperform and lowers the price target from $190 to $180.",
                "category": "company",
                "datetime": 1783338081,
                "headline": "Evercore ISI Group Maintains Outperform on Becton Dickinson, Lowers Price Target to $180"
              },
              {
                "id": 140802850,
                "url": "https://finnhub.io/api/news?id=c5905c968be2d149392bf23b184b1bb711768e2b822b0fb6621edca56d2e06a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.",
                "category": "company",
                "datetime": 1783100460,
                "headline": "WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?"
              },
              {
                "id": 140794039,
                "url": "https://finnhub.io/api/news?id=8831e57c447685f7d89edb07b4c239f2b6fa697dd0711d22279e85d63efc7d36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "While a guidance cut has reset expectations, several core Boston Scientific franchises are accelerating. The Neuromodulation and Interventional Oncology businesses both posted organic sales growth of 15% last quarter. This internal momentum in high-value categories contrasts sharply with the new, more cautious company-wide outlook.",
                "category": "company",
                "datetime": 1783013922,
                "headline": "What Could Push BSX Stock Higher From Here?"
              },
              {
                "id": 140787370,
                "url": "https://finnhub.io/api/news?id=7a79c4dc986fb813b3fed3666730ff4fef46a893a26ce53053e03b57a9e8729c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2194222722/image_2194222722.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "Becton, Dickinson and Company boasts a few high-margin, high-growth product lines that should fuel a return to sustainable growth. Read why BDX stock is a Buy.",
                "category": "company",
                "datetime": 1782953649,
                "headline": "Becton, Dickinson and Company: Now Is A Great Time To Buy"
              },
              {
                "id": 140780455,
                "url": "https://finnhub.io/api/news?id=aaad818871fc103be361a4ce44426e192688552a3c7b5611a6eda8231c4c61e2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323538000/image_1323538000.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BDX",
                "summary": "BDX looks undervalued at 12–13x P/E with 7–8% growth, a 2.78% dividend, buybacks, and debt reduction. Click for more on BDX stock.",
                "category": "company",
                "datetime": 1782905539,
                "headline": "Becton, Dickinson - Stable Undervaluation In 1Q26, Upside Is There"
              },
              {
                "id": 140778426,
                "url": "https://finnhub.io/api/news?id=67539a3ffd65f04ec9465c4dcd6ed59833c967b2e4269a76cae2a090d82941f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "Becton, Dickinson & Company (NYSE:BDX) is one of the best value stocks to buy right now. On June 23, BD (Becton, Dickinson & Company) announced that its CentroVena One Insertion System was awarded an Innovative Technology contract by Vizient, the nation’s largest provider-driven healthcare performance improvement company. This contract recognizes the system as a breakthrough […]",
                "category": "company",
                "datetime": 1782893774,
                "headline": "BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System"
              },
              {
                "id": 140771662,
                "url": "https://finnhub.io/api/news?id=8a15f5817679e8349c5c9ce173c3041ec8b1477d09f97686cfc439e64e805427",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BDX",
                "summary": "The global IV equipment market is set to reach USD 23.92 billion by 2031, expanding from USD 17.82 billion in 2026, at a CAGR of 6.1%. Growth is fueled by rising chronic disease prevalence and increasing hospitalizations, along with a shift towards home-based and outpatient care. Technological advancements such as needle-free connectors and smart infusion pumps are elevating market adoption. North America leads the market, driven by a robust healthcare infrastructure and high adoption of medical",
                "category": "company",
                "datetime": 1782819120,
                "headline": "IV Equipment Market by Type, Application, End User - Global Forecast to 2031"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 4,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 27,
            "discarded_article_count": 23
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.3,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 3,
          "vcpPoints": 1.5,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日5日)；站上MA50；收盤突破20日高位；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 2413420,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1598320,
              "avg_vol_20": 1721620,
              "avg_vol_30": 2413420,
              "range_pct_10": 0.08897438980401577,
              "range_pct_20": 0.08963568594445111,
              "range_pct_30": 0.13845136467476238,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.6622635098739548,
              "dist_to_20d_high": -0.019615054554370584,
              "down_shrink_days": 5,
              "breakout_level_20d": 163.14,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.6426400347372991
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.6353252374654326,
              "turnoverUsdM": 322.13554106,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.BDX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 157.5728,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 5.3,
            "take_profit_price": 176.6122,
            "target_multiplier": 1.9,
            "technical_strength": 1.85,
            "take_profit_percent": 6.2
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.270650474930865,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 4.3836,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.64
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 243.13
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0119
    },
    "kdj": {
      "d": 53.66,
      "j": 85.44,
      "k": 64.25,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 62.99
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 5636609,
      "recentSlope": -186449.1,
      "previousSlope": 648180
    },
    "rsi": 71.88,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 10,
      "trend": "上升",
      "value": 151.97,
      "position": "SAR由上轉下+趨勢強",
      "distancePct": 8.64,
      "previousTrend": "下降"
    },
    "ma50": 150.3162,
    "macd": {
      "macd": 2.5562600346638362,
      "trend": "強烈看漲",
      "signal": 1.8712018696721167,
      "histogram": 0.6850581649917196
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 155.1115,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 3
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.14,
      "score": 6,
      "avgVolume": 1698620,
      "currentVolume": 1936609
    },
    "derived": {
      "ma20": 155.0515,
      "ma50": 150.3162,
      "prevClose": 158.92,
      "avgVolume10": 1601171,
      "avgVolume20": 1698620,
      "changePercent": 4.67,
      "avgVolumeForScore": 1698620
    },
    "ma_cross": {
      "ma20": 155.0515,
      "ma50": 150.3162,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 154.494,
      "prevMa50": 149.8788,
      "spreadPct": 3.15,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 147.4992,
      "upper": 162.6038,
      "position": "上半部"
    },
    "rsi_short": 89.85,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.14
    }
  }
}

{
  "close": 166.34,
  "volume": 1936609,
  "changePercent": 4.67
}